Literature DB >> 12823749

Probability of anti-D development in D- patients receiving D+ RBCs.

Christoph Frohn1, Lutz Dümbgen, Jörg-Matthias Brand, Siegfried Görg, Jürgen Luhm, Holger Kirchner.   

Abstract

BACKGROUND: In some situations, the administration of D+ RBCs to D- patients is necessary. The probability of a subsequent anti-D formation is assumed to be around 80 percent, a figure based primarily on studies in healthy volunteers. It was hypothesized that patients requiring blood transfusion have a much lower probability of developing antibodies. STUDY DESIGN AND METHODS: A retrospective analysis was performed whereby 78 D- patients were evaluated for the development of RBC antibodies after administration of D+ RBCs. For the analysis of the cross-sectional observations, parametric models were used for interval-censored data.
RESULTS: Anti-D was detected in 16 of 78 patients. Considering the individual patient's inspection times, the calculated probability of developing antibody following D+ RBC supply was shown to be below 41.7 percent (upper 95% confidence bound) and estimated as 30.4 percent. The data hinted toward an inverse correlation between the number of transfused units and the probability of antibody formation. Interestingly, 6 of these 16 patients developed additional IgG autoantibody. In 3 of those cases, evidence for prolonged hemolysis was found.
CONCLUSION: The actual frequency of antibody formation in our patients is much lower than assumed. On the other hand, prolonged hemolysis probably induced by additional autoreactive antibodies might occur. This possible complication has not yet been addressed. Further studies might reveal whether a less restricted transfusion policy with respect to D matching is justified in selected patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823749     DOI: 10.1046/j.1537-2995.2003.00394.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Authors:  Nicole H Smith; Eldad A Hod; Steven L Spitalnik; James C Zimring; Jeanne E Hendrickson
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Minor RBC Ab and allo-SCT.

Authors:  G S Booth; E A Gehrie; B N Savani
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

3.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

4.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

5.  Rh and Kell Phenotype Matched Blood Versus Randomly Selected and Conventionally Cross Matched Blood on Incidence of Alloimmunization.

Authors:  Raj Nath Makroo; Soma Agrawal; Mohit Chowdhry
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-05       Impact factor: 0.900

Review 6.  Red blood cell transfusion risks in patients with end-stage renal disease.

Authors:  Yvette C Tanhehco; Jeffrey S Berns
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

7.  Application of a Multivariant, Caucasian-Specific, Genotyped Donor Panel for Performance Validation of MDmulticard®, ID-System®, and Scangel® RhD/ABO Serotyping.

Authors:  Christoph Gassner; Esther Rainer; Elfriede Pircher; Lydia Markut; Günther F Körmöczi; Christof Jungbauer; Dietmar Wessin; Roswitha Klinghofer; Harald Schennach; Peter Schwind; Diether Schönitzer
Journal:  Transfus Med Hemother       Date:  2009-05-18       Impact factor: 3.747

Review 8.  Responder individuality in red blood cell alloimmunization.

Authors:  Günther F Körmöczi; Wolfgang R Mayr
Journal:  Transfus Med Hemother       Date:  2014-10-28       Impact factor: 3.747

9.  Rhesus Negative Woman Transfused With Rhesus Positive Blood: Subsequent Normal Pregnancy Without Anti D production.

Authors:  E T Maya; K A Buntugu; F Pobee; E K Srofenyoh
Journal:  Ghana Med J       Date:  2015-03

10.  Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.

Authors:  Joan Cid; Miguel Lozano; Alyssa Ziman; Kamille A West; Kerry L O'Brien; Michael F Murphy; Silvano Wendel; Alejandro Vázquez; Xavier Ortín; Tor A Hervig; Meghan Delaney; Willy A Flegel; Mark H Yazer
Journal:  Br J Haematol       Date:  2014-10-04       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.